These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11343676)

  • 1. Gadolinium-enhanced cardiac magnetic resonance imaging: expanding the spectrum of clinical applications.
    Danias PG
    Am J Med; 2001 May; 110(7):591-2. PubMed ID: 11343676
    [No Abstract]   [Full Text] [Related]  

  • 2. Demonstration of cardiac involvement of sarcoidosis by contrast-enhanced multislice computed tomography and delayed-enhanced magnetic resonance imaging.
    Kanao S; Tadamura E; Yamamuro M; Kubo S; Kimura T; Kita T; Togashi K
    J Comput Assist Tomogr; 2005; 29(6):745-8. PubMed ID: 16272844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis of cardiac sarcoidosis and evaluation of the effects of corticosteroid therapy by gadolinium-DTPA-enhanced MRI].
    Launay D
    Rev Med Interne; 2001 Nov; 22(11):1137-8. PubMed ID: 11817132
    [No Abstract]   [Full Text] [Related]  

  • 4. Usefulness of late gadolinium enhancement combined with MRI and 67-Ga scintigraphy in the diagnosis of cardiac sarcoidosis and disease activity evaluation.
    Kiuchi S; Teraoka K; Koizumi K; Takazawa K; Yamashina A
    Int J Cardiovasc Imaging; 2007 Apr; 23(2):237-41. PubMed ID: 16868855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of gadolinium-DTPA-enhanced MRI for detection of myocardial lesions in a patient with sarcoidosis.
    Inoue S; Shimada T; Murakami Y
    Clin Radiol; 1999 Jan; 54(1):70-2. PubMed ID: 9915515
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis.
    Smedema JP; Snoep G; van Kroonenburgh MP; van Geuns RJ; Dassen WR; Gorgels AP; Crijns HJ
    J Am Coll Cardiol; 2005 May; 45(10):1683-90. PubMed ID: 15893188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visualization of cardiac involvement in patients with systemic sarcoidosis applying contrast-enhanced magnetic resonance imaging.
    Schulz-Menger J; Strohm O; Dietz R; Friedrich MG
    MAGMA; 2000 Nov; 11(1-2):82-3. PubMed ID: 11186999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late gadolinium enhanced high resolution magnetic resonance imaging reveals pathophysiological condition of cardiac sarcoidosis.
    Niida T; Isoda K; Sasaki M; Horikawa M; Hayashi K; Ohsuzu F
    Int Heart J; 2009 Mar; 50(2):263-6. PubMed ID: 19367036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early diagnosis of cardiac sarcoidosis using magnetic resonance imaging.
    Osman F; Foundon A; Leyva P; Pitt M; Murray RG
    Int J Cardiol; 2008 Mar; 125(1):e4-5. PubMed ID: 17337076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac MRI for Detection of Cardiac Sarcoidosis.
    Romano S; Farzaneh-Far A
    Radiology; 2018 Sep; 288(3):659. PubMed ID: 30015582
    [No Abstract]   [Full Text] [Related]  

  • 11. Comprehensive Cardiovascular Magnetic Resonance Assessment in Patients With Sarcoidosis and Preserved Left Ventricular Ejection Fraction.
    Greulich S; Kitterer D; Latus J; Aguor E; Steubing H; Kaesemann P; Patrascu A; Greiser A; Groeninger S; Mayr A; Braun N; Alscher MD; Sechtem U; Mahrholdt H
    Circ Cardiovasc Imaging; 2016 Nov; 9(11):. PubMed ID: 27903537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial stress perfusion-fibrosis imaging pattern in sarcoidosis, assessed by cardiovascular magnetic resonance imaging.
    Mavrogeni S; Kouranos V; Sfikakis PP; Bratis K; Kitas GD; Manali E; Perros E; Vlasis K; Rapti A; Koulouris N; van Wijk K; Hautemann D; Reiber JH; Kolovou G; Tzelepis GE; Gialafos E
    Int J Cardiol; 2014 Mar; 172(2):501-3. PubMed ID: 24476697
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging.
    Shimada T; Shimada K; Sakane T; Ochiai K; Tsukihashi H; Fukui M; Inoue S; Katoh H; Murakami Y; Ishibashi Y; Maruyama R
    Am J Med; 2001 May; 110(7):520-7. PubMed ID: 11343665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconciling Q waves and late gadolinium enhancement with no angiographic evidence of coronary disease: cardiac sarcoidosis presenting as decompensated heart failure.
    Morrissey RP; Philip KJ; Schwarz ER
    Cardiovasc J Afr; 2010; 21(3):158-63. PubMed ID: 20532456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis.
    Ise T; Hasegawa T; Morita Y; Yamada N; Funada A; Takahama H; Amaki M; Kanzaki H; Okamura H; Kamakura S; Shimizu W; Anzai T; Kitakaze M
    Heart; 2014 Aug; 100(15):1165-72. PubMed ID: 24829369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiac MRI in suspected myocarditis].
    Rieker O; Mohrs O; Oberholzer K; Kreitner KF; Thelen M
    Rofo; 2002 Dec; 174(12):1530-6. PubMed ID: 12471525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QRS-based assessment of myocardial damage and adverse events associated with cardiac sarcoidosis.
    Sobue Y; Harada M; Koshikawa M; Ichikawa T; Yamamoto M; Okuda K; Kato Y; Sarai M; Watanabe E; Ozaki Y
    Heart Rhythm; 2015 Dec; 12(12):2499-507. PubMed ID: 26362576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial delayed contrast-enhanced MRI: relationships between various enhancing patterns and myocardial diseases.
    Sueyoshi E; Sakamoto I; Uetani M
    Br J Radiol; 2009 Aug; 82(980):691-7. PubMed ID: 19098085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of late gadolinium enhancement MRI and quantitative T2 measurement in cardiac sarcoidosis.
    Yang Y; Safka K; Graham JJ; Roifman I; Zia MI; Wright GA; Balter M; Dick AJ; Connelly KA
    J Magn Reson Imaging; 2014 Mar; 39(3):609-16. PubMed ID: 23720077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late gadolinium enhancement in cardiac sarcoidosis: characteristic magnetic resonance findings and relationship with left ventricular function.
    Watanabe E; Kimura F; Nakajima T; Hiroe M; Kasai Y; Nagata M; Kawana M; Hagiwara N
    J Thorac Imaging; 2013 Jan; 28(1):60-6. PubMed ID: 23249970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.